Geneva, June 4 -- International Clinical Trials Registry received information related to the study (ISRCTN16864220) titled 'Quetiapine effectiveness study in borderline personality disorder (QUEST)' on May 20.
Study Type: Interventional
Study Design:
Interventional double blind randomized parallel group placebo controlled trial (Safety, Efficacy)
Primary Sponsor: University of Liverpool
Condition:
Borderline personality disorder
Mental and Behavioural Disorders
Intervention:
Participants will be randomised (ratio 1:1) via a secure, 24-hour, web-based randomisation system controlled centrally by the LCTC to receive either quetiapine or matched placebo.
Route of administration: oral
IMP: Quetiapine prolonged release tablets (over...